StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.28+0.10 (+2.39%)

Close on Nov 18, 2026Market cap $106.09MP/E –Yield –

Lexaria Bioscience pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lexaria Bioscience's pe ratio was 93.9× on Sep 30, 2020, against 73.7× a year earlier. Over the last 2 years it ranged from 73.7× to 266.1×, with a median of 138.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Sep 30, 202093.9×−16.4
2019Dec 31, 2019110.3×−49.4
2018Dec 31, 2018159.7×–

More Lexaria Bioscience figures

See a number that looks wrong?